Long-Acting Cabotegravir Plus VRC-HIVMAB075-00-AB (VRC07-523LS) for Viral Suppression in Adults Living With HIV-1
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Leah Burke, MD
Weill Cornell Chelsea CRS
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Puerto Rico Aids Clinical Trials Unit Crs
San Juan, Puerto Rico
- Alabama Crs
Birmingham, Alabama, United States
- Ucsd Antiviral Research Center Crs
San Diego, California, United States
- Ucsf Hiv/aids Crs
San Francisco, California, United States
- University of Colorado Hospital Crs
Aurora, Colorado, United States
- Northwestern University Crs
Chicago, Illinois, United States
- Johns Hopkins University Crs
Baltimore, Maryland, United States
- Washington University Therapeutics (wt) Crs
St Louis, Missouri, United States
- New Jersey Medical School Clinical Research Center Crs
Newark, New Jersey, United States
- Columbia P&s Crs
New York, New York, United States
- Weill Cornell Chelsea Crs
New York, New York, United States
- Weill Cornell Uptown Crs
New York, New York, United States
- University of Rochester Adult Hiv Therapeutic Strategies Network Crs
Rochester, New York, United States
- Chapel Hill Crs
Chapel Hill, North Carolina, United States
- Cincinnati Clinical Research Site
Cincinnati, Ohio, United States
- Ohio State University Crs
Columbus, Ohio, United States
- Penn Therapeutics, Crs
Philadelphia, Pennsylvania, United States
- University of Washington Aids Crs
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2019
- Primary completion
- 29 Apr 2024
- Completion
- 29 Apr 2024
- Last update posted
- 23 May 2025
- Registered enrollment
- 75
- Registry id
- NCT03739996
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.